Immunoexpression of SPANX-C in metastatic uveal melanoma

Pathol Res Pract. 2019 Jul;215(7):152431. doi: 10.1016/j.prp.2019.04.023. Epub 2019 Apr 29.

Abstract

Uveal melanoma is a rare disease but it is the most common primary intraocular malignant tumor in adults with poor late prognosis. About 50% of patients will develop liver metastasis far from the enucleation within 10-15 years. Our study examined SPANX-C expression levels in primary uveal melanoma both with and without metastasis to assess if they can be used to predict metastasis. This study included a total of 55 patients, 28 males and 27 females, with uveal melanoma. A significantly high expression of SPANX-C was seen in 19/23 (82.6%) patients with metastasis, and only in 11/32 (38.5%) patients without metastasis. In conclusion, we found that SPANX-C expression could play a role in tumor progression of uveal melanoma.

Keywords: Immunohistochemistry; Metastasis; SPANX-C; Trailblazer cells; Uveal melanoma.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / secondary
  • Male
  • Melanoma / metabolism*
  • Melanoma / secondary
  • Middle Aged
  • Neoplasm Proteins / metabolism*
  • Prognosis
  • Uveal Neoplasms / metabolism*
  • Uveal Neoplasms / pathology

Substances

  • Neoplasm Proteins
  • SPANXC protein, human